Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is an early-stage adaptation and usability study of a newly modified intervention with a single small uncontrolled group, generating preliminary evidence of acceptability but not efficacy.
A cross-sectional study using advanced imaging (HR-pQCT) to detect bone health impairment missed by standard DXA in pediatric ALL survivors; real findings in a limited sample that warrant confirmation in larger, prospective cohorts.
Systematic review and meta-analysis of occupational therapy in pediatric cancer showing potential benefit across multiple domains, but with incomplete reported effect sizes and heterogeneous study quality limiting definitive conclusions.
Retrospective cohort study confirming that younger age predicts better melanoma survival; well-designed with adequate sample and long follow-up, but uses observational data and a single centre, limiting practice-changing impact.
This is a protocol for an ongoing feasibility study with interim recruitment data (2 of 10 enrolled as of manuscript submission); no outcome data have been analysed yet.
This is a development and feasibility study describing the creation of a prehabilitation intervention, not yet reporting efficacy or safety outcomes; the phase III trial is ongoing and will provide the evidence needed to judge clinical impact.
A single-centre cross-sectional study identifying modifiable and non-modifiable factors associated with HRQoL in paediatric leukaemia using validated instruments and multivariable regression, with moderate sample size and substantial explained variance, but lacking a comparator or control group.